synthesi
sever
amin
report
evalu
nmda
receptor
antagonist
sever
activ
amantadin
none
potent
memantin
none
test
compound
display
antivir
activ
two
deriv
show
signific
level
trypanocid
activ
base
interest
wide
observ
biolog
activ
amantadin
memantin
therefor
sought
explor
biolog
profil
amin
deriv
paper
report
synthesi
sever
amin
relat
compound
pharmacolog
evalu
nmda
receptor
antagonist
antivir
trypanocid
agent
result
discuss
start
known
diketon
prepar
amin
use
classic
method
amin
chemistri
see
scheme
secondari
amin
obtain
high
yield
follow
known
gener
procedur
involv
reduct
amin
diketon
thu
reaction
benzylamin
follow
reduct
lialh
led
amin
yield
similarli
reduct
amin
phenethylamin
furnish
amin
yield
reduct
alkyl
amin
b
formaldehyd
sodium
cyanoborohydrid
afford
tertiari
amin
b
high
yield
hydrogenolysi
benzyl
group
amin
led
respect
final
alkyl
benzyl
chlorid
led
yield
alcohol
gener
structur
prepar
use
gener
method
develop
time
ago
group
sever
attempt
carri
substitut
hydroxyl
group
wide
rang
amin
led
recoveri
start
materi
moreov
attempt
ritter
reaction
acetonitril
acid
medium
led
known
enon
high
yield
howev
reaction
aqueou
hydrazin
led
hydrazin
high
yield
probabl
due
ensur
higher
nucleophil
hydrazin
even
though
reaction
fail
case
catalyt
hydrogen
b
furnish
amin
b
high
yield
surprisingli
led
mixtur
expect
amin
cyclohexyl
deriv
ratio
product
separ
column
chromatographi
reduct
methyl
amin
formaldehyd
sodium
cyanoborohydrid
afford
tertiari
amin
respect
similar
way
reduct
alkyl
acetaldehyd
benzaldehyd
led
amin
respect
final
secondari
amin
synthes
benzylamin
reduct
alkyl
follow
catalyt
debenzyl
good
overal
yield
structur
new
compound
confirm
element
analysi
accur
mass
measur
ir
h
nmr
c
nmr
mass
spectral
data
last
year
intens
research
develop
new
nmda
receptor
antagonist
sinc
subtyp
receptor
involv
apoptot
process
develop
neurodegen
diseas
memantin
noncompetit
low
affin
blocker
act
select
nmda
receptor
use
alzheim
diseas
slow
progress
amantadin
analogu
memantin
nmda
receptor
antagonist
approv
treatment
parkinson
alzheim
diseas
respect
amantadin
also
prophylact
therapeut
activ
influenza
viru
infect
relat
adamantan
deriv
show
antivir
activ
moreov
amantadin
memantin
relat
polycycl
amin
possess
trypanocid
properti
well
known
medicin
chemistri
substitut
methylen
unit
bioactiv
compound
oxygen
atom
usual
lead
analogu
show
similar
activ
parent
compound
inde
brainperm
oxapolycycl
cage
amin
dual
action
uncompetit
nmda
receptor
antagonist
blocker
ltype
calciumchannel
addit
sever
experi
shown
neuroprotect
activ
fig
intracellular
calcium
challeng
cumul
addit
compound
test
data
present
tabl
indic
presenc
substitu
nucleu
essenti
nmda
receptor
antagon
thu
primari
amin
nalkyl
ndialkyl
deriv
b
b
inact
case
methyl
deriv
phenyl
deriv
weak
nmda
receptor
antagonist
lipophil
amin
show
similar
potenc
amantadin
enhanc
potenc
achiev
alkyl
activ
deriv
tertiari
amin
seven
time
potent
amantadin
still
ten
time
less
potent
memantin
contrari
expect
benzyl
deriv
found
inact
strike
contrast
featur
benzyl
group
essenti
nmda
receptor
antagon
previou
work
group
found
benzyl
ringcontract
analogu
amantadin
show
nmda
receptor
antagon
primari
amin
secondari
amin
test
antivir
activ
none
test
compound
display
activ
envelop
dna
virus
herp
simplex
viru
type
type
vaccinia
viru
envelop
rna
virus
felin
coronaviru
viru
respiratori
syncyti
viru
vesicular
stomat
viru
sindbi
viru
punta
toro
viru
nonenvelop
rna
virus
coxsackieviru
also
none
compound
found
activ
influenza
viru
b
protozoan
parasit
trypanosoma
brucei
speci
complex
caus
agent
african
trypanosomiasi
diseas
invari
fatal
unless
treat
howev
current
drug
character
toxic
need
administr
medic
supervis
mani
case
lack
efficaci
new
drug
combat
import
diseas
urgent
need
rang
adamantylamin
compound
trypanocid
activ
therefor
investig
whether
properti
also
extend
amin
deriv
new
deriv
describ
paper
test
potenc
cultur
bloodstream
form
brucei
case
nmda
receptor
antagon
presenc
substitut
posit
nucleu
found
essenti
trypanocid
activ
compound
tertiari
amin
b
found
activ
amin
ic
ic
trimethyl
deriv
ic
ic
amin
potent
compound
test
approxim
twice
activ
rimantadin
ic
ic
least
time
activ
amantadin
ic
amin
b
b
lack
substitut
activ
concentr
mg
ml
primari
secondari
amin
also
display
signific
trypanocid
properti
even
though
carri
substitut
posit
sever
adamantan
deriv
previous
shown
trypanocid
properti
howev
oxanalogu
report
first
heteroadamantan
show
signific
activ
bloodstream
form
brucei
summari
synthes
fulli
character
sever
amin
presenc
substitut
posit
essenti
nmda
receptor
antagon
although
potent
amantadin
nmdainduc
calcium
increas
cerebellar
granul
neuron
less
potent
memantin
contrast
model
compound
benzyl
deriv
devoid
nmda
receptor
antagon
activ
none
test
compound
show
antivir
activ
two
tertiari
amin
display
signific
level
trypanocid
activ
twice
activ
rimantadin
mechan
adamantylamin
deriv
kill
trypanosom
unknown
hypothes
analog
known
properti
class
compound
may
involv
channel
block
activ
data
obtain
trimethyl
amin
provid
basi
explor
relat
deriv
enhanc
activ
synthesi
pharmacolog
evalu
polycycl
cage
amin
progress
determin
open
capillari
tube
unless
otherwis
state
nmr
spectra
record
cd
od
follow
spectromet
h
nmr
mhz
c
nmr
mhz
chemic
shift
report
ppm
relat
intern
tetramethylsilan
tm
assign
given
nmr
spectra
base
dept
cosi
h
h
hetcor
h
c
hsqc
hmbc
sequenc
one
bond
long
rang
h
c
heterocorrel
respect
noesi
experi
select
compound
ms
gcm
analys
sampl
introduc
directli
ga
chromatograph
gcm
analys
column
dimethylpolysiloxan
condit
psi
initi
temperatur
min
heat
rang
till
isotherm
use
electron
impact
ev
chemic
ioniz
ch
techniqu
use
signific
ion
given
higher
rel
abund
except
ion
higher
mz
valu
accur
mass
measur
obtain
use
esi
technic
absorpt
valu
ir
spectra
kbr
given
wavenumb
cm
intens
band
given
column
chromatographi
perform
silica
gel
mesh
thin
layer
chromatographi
tlc
aluminumback
sheet
silica
gel
f
use
spot
visual
uv
light
andor
aqueou
solut
kmno
diketon
g
mmol
anhyd
thf
ml
benzylamin
g
mmol
ad
solut
reflux
min
cool
icebath
solut
ad
dropwis
stir
vigor
suspens
lialh
g
mmol
anhyd
diethyl
ether
ml
mixtur
stir
h
cool
icebath
n
naoh
ml
ad
dropwis
precipit
form
filter
clear
filtrat
dri
anhyd
na
filter
concentr
vacuo
give
oili
residu
g
residu
dissolv
aceton
ml
concd
hcl
ml
ad
solut
cool
whereupon
precipit
hydrochlorid
crystal
gave
pure
g
yield
mp
lit
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
cm
h
nmr
dm
j
hz
h
ax
dquint
j
hz
j
hz
syn
dtt
j
hz
j
hz
j
hz
n
cl
found
c
h
n
cl
hclfrom
g
mmol
phenethylamin
g
mmol
anhyd
thf
ml
follow
procedur
amin
obtain
hydrochlorid
g
yield
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ch
ch
c
h
ch
ch
mg
mmol
acetonitril
ml
formaldehyd
ml
wt
water
solut
mmol
nabh
cn
mg
mmol
ad
mixtur
stir
min
room
temperatur
acet
acid
ml
ad
mixtur
stir
room
temperatur
h
addit
portion
nabh
cn
mg
mmol
ad
mixtur
stir
room
temperatur
h
mixtur
concentr
dryness
n
naoh
ml
ad
suspens
extract
ch
cl
ml
combin
organ
phase
wash
h
ml
dri
anhyd
na
filter
concentr
vacuo
give
mg
yield
white
solid
analyt
sampl
obtain
crystal
ch
cl
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
n
found
c
h
n
solut
mg
mmol
acetonitril
ml
formaldehyd
ml
wt
water
solut
mmol
nabh
cn
mg
mmol
ad
mixtur
stir
min
room
temperatur
acet
acid
ml
ad
mixtur
stir
room
temperatur
h
addit
portion
nabh
cn
mg
mmol
ad
mixtur
stir
room
temperatur
h
mixtur
concentr
dryness
n
naoh
ml
ad
suspens
extract
ch
cl
ml
combin
organ
phase
wash
h
ml
dri
anhyd
na
filter
concentr
vacuo
give
mg
yield
white
solid
hydrochlorid
obtain
ad
excess
et
solut
amin
etoac
analyt
sampl
obtain
crystal
etoac
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ch
ch
c
h
ch
ch
ch
n
ch
c
ch
arc
para
ch
ch
arc
ortho
arc
meta
c
arc
ipso
ms
ei
mz
cl
found
c
h
n
cl
mg
mmol
pdc
water
mg
absolut
etoh
ml
hydrogen
atm
h
suspens
filter
residu
wash
etoh
combin
organ
filtrat
excess
et
ad
evapor
solvent
filtrat
vacuo
follow
crystal
meohet
gave
mg
yield
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
anal
calcd
c
h
c
h
n
cl
found
c
h
n
cl
amin
hydrochlorid
mixtur
g
mmol
pdc
water
mg
absolut
etoh
ml
hydrogen
atm
h
suspens
filter
residu
wash
etoh
combin
organ
filtrat
concentr
vacuo
give
solid
n
naoh
ml
ad
residu
extract
etoac
ml
combin
organ
extract
dri
anhyd
na
filter
concentr
vacuo
give
residu
sublim
torr
give
amin
hydrochlorid
g
yield
obtain
ad
excess
solut
hcl
meoh
amin
follow
concentr
vacuo
analyt
sampl
obtain
crystal
meoh
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
ndibenzyl
amin
suspens
mg
mmol
k
co
mg
mmol
benzyl
chlorid
ml
mmol
nai
mg
mmol
acetonitril
ml
heat
reflux
h
cold
mixtur
ch
cl
ml
ad
solut
wash
water
ml
organ
layer
dri
anhyd
na
filter
concentr
vacuo
residu
crystal
etoac
give
amin
mg
yield
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
g
mmol
pto
mg
absolut
etoh
ml
hydrogen
atm
room
temperatur
day
suspens
filter
residu
wash
absolut
etoh
combin
organ
filtrat
concentr
vacuo
dryness
obtain
white
residu
taken
water
ml
solut
basifi
n
naoh
extract
etoac
ml
combin
organ
extract
dri
anhyd
na
concentr
vacuo
dryness
residu
taken
minimum
amount
acoet
solut
treat
excess
solut
hcl
et
precipit
filter
wash
et
give
g
yield
analyt
sampl
obtain
crystal
meoh
mp
ir
g
mmol
pto
mg
absolut
etoh
ml
follow
procedur
describ
amin
obtain
hydrochlorid
mg
yield
analyt
sampl
obtain
crystal
meoh
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
amin
hydrochlorid
amin
hydrochlorid
g
mmol
pto
mg
absolut
etoh
ml
follow
procedur
describ
mixtur
amin
obtain
hydrochlorid
mixtur
dilut
water
ml
n
naoh
ad
till
basic
ph
suspens
extract
etoac
ml
combin
organ
phase
dri
anhyd
na
filter
concentr
vacuo
give
mixtur
h
n
cl
found
c
h
n
cl
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
n
ndimethyl
amin
hydrochlorid
cold
solut
mg
mmol
et
ml
formaldehyd
ml
wt
water
solut
mmol
formic
acid
ml
mmol
ad
dropwis
mixtur
stir
h
cold
mixtur
dilut
et
ml
n
naoh
ml
ad
dropwis
suspens
stir
room
temperatur
min
organ
layer
separ
aqueou
phase
extract
et
ml
combin
organ
phase
dri
anhyd
na
filter
treat
excess
et
concentr
mixtur
vacuo
gave
analyt
sampl
mg
yield
obtain
crystal
meohet
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
solut
mg
mmol
methanol
ml
nabh
cn
mg
mmol
acoh
ml
acetaldehyd
ml
mmol
ad
mixtur
stir
room
temperatur
h
addit
portion
nabh
cn
mg
mmol
acetaldehyd
ml
mmol
ad
mixtur
stir
room
temperatur
h
concentr
vacuo
dryness
water
ml
ad
residu
suspens
basifi
nahco
satur
aqueou
solut
extract
etoac
ml
combin
organ
extract
dri
anhyd
na
filter
concentr
vacuo
residu
taken
etoac
mg
yield
precipit
ad
excess
solut
hcl
et
analyt
sampl
obtain
crystal
meohet
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
mp
ir
nmethyl
n
cl
found
c
h
n
cl
function
assay
antagonist
activ
nmda
receptor
perform
use
primari
cultur
cerebellar
granul
neuron
prepar
accord
establish
protocol
cell
grown
mm
polyllysineco
glass
cover
slip
use
experi
day
vitro
cell
load
invitrogenmolecular
probe
min
afterward
coverslip
mount
quartz
cuvett
contain
lockehep
buffer
use
special
holder
measur
perform
use
perkinelm
fluoromet
equip
fastfilt
accessori
mild
agit
analysi
sampl
record
realtim
stimul
nmda
glutam
presenc
glycin
increas
cumul
concentr
compound
test
ad
percentag
inhibit
everi
test
concentr
analyz
use
nonlinear
regress
curv
fit
variabl
slope
use
softwar
graphpad
prism
antivir
activ
compound
determin
establish
cell
cultur
assay
use
select
dna
rna
virus
includ
three
subtyp
influenza
viru
puerto
ahong
bhong
compound
inhibitori
effect
viru
replic
well
cytotox
monitor
microscop
examin
confirm
colorimetr
mt
cell
viabil
assay
cultur
bloodstream
form
brucei
strain
maintain
modifi
iscov
medium
ph
trypanocid
activ
assess
grow
parasit
h
presenc
variou
drug
concentr
determin
level
inhibit
growth
ic
ic
case
untreat
cultur
volum
ml
cell
densiti
increas
cell
ml
period
experi
perform
triplic
cell
densiti
drug
concentr
determin
use
hemocytomet
weber
scientif
intern
ltd
drug
sensit
express
percentag
growth
control
cell
amantadin
memantin
structur
